Lifestyle factors (e.g., overweight/obesity and stress) seem to be the main drivers of the current type 2 diabetes epidemic. Particular conditions can increase the risk of type 2 diabetes. These include cardiovascular disease, hypertension, dyslipidaemia, obesity, stroke, polycystic ovary syndrome, a history of gestational diabetes, and mental health problems.[27]National Institute for Health and Care Excellence. Type 2 diabetes: prevention in people at high risk. September 2017 [internet publication].
https://www.nice.org.uk/guidance/ph38
[34]American Diabetes Association. Standards of care in diabetes - 2024. Diabetes Care. 2024 Jan;47(suppl 1):S1-321.
https://diabetesjournals.org/care/issue/47/Supplement_1
The National Institute for Health and Care Excellence (NICE) in the UK recommends a two-stage strategy to identify people at high risk of type 2 diabetes (and those with undiagnosed type 2 diabetes): a risk assessment and, if necessary, a confirmatory blood test.[27]National Institute for Health and Care Excellence. Type 2 diabetes: prevention in people at high risk. September 2017 [internet publication].
https://www.nice.org.uk/guidance/ph38
NICE recommends that general practitioners (primary care physicians) use a validated computer-based risk-assessment tool to identify people on their practice register who may be at high risk of type 2 diabetes.[27]National Institute for Health and Care Excellence. Type 2 diabetes: prevention in people at high risk. September 2017 [internet publication].
https://www.nice.org.uk/guidance/ph38
In addition, it recommends that pharmacists, opticians, occupational health nurses, and community leaders should offer a validated self-assessment questionnaire or validated web-based tools to:[27]National Institute for Health and Care Excellence. Type 2 diabetes: prevention in people at high risk. September 2017 [internet publication].
https://www.nice.org.uk/guidance/ph38
All adults aged 40 and above (except pregnant women)
People aged 25 to 39 of South Asian, Chinese, African-Caribbean, and black African ethnicity (except pregnant women)
Adults with any other condition that increases the risk of type 2 diabetes.
Those with a high risk score should be advised to contact their GP or practice nurse for a fasting plasma glucose or HbA1c test.[27]National Institute for Health and Care Excellence. Type 2 diabetes: prevention in people at high risk. September 2017 [internet publication].
https://www.nice.org.uk/guidance/ph38
In addition, a blood test should also be considered regardless of risk score for those aged 25 years and over of South Asian or Chinese descent whose body mass index (BMI) is greater than 23 kg/m².[27]National Institute for Health and Care Excellence. Type 2 diabetes: prevention in people at high risk. September 2017 [internet publication].
https://www.nice.org.uk/guidance/ph38
People identified as being at high risk of progression to type 2 diabetes, that is, having non-diabetic hyperglycaemia, NDH (defined as fasting plasma glucose of 5.5 to 6.9 mmol/L [99.0 to 124.2 mg/dL] or HbA1c of 42 to 47 mmol/mol [6.0% to 6.4%]) should be offered a referral to an evidence-based, quality-assured intensive lifestyle-change programme.[27]National Institute for Health and Care Excellence. Type 2 diabetes: prevention in people at high risk. September 2017 [internet publication].
https://www.nice.org.uk/guidance/ph38
[44]NHS England. NHS diabetes prevention programme (NHS DPP) [internet publication].
https://www.england.nhs.uk/diabetes/diabetes-prevention
In England, one such programme is the NHS Diabetes Prevention Programme (DPP), also called the ‘Healthier You’ programme.[44]NHS England. NHS diabetes prevention programme (NHS DPP) [internet publication].
https://www.england.nhs.uk/diabetes/diabetes-prevention
It identifies people at risk of developing type 2 diabetes and enrolls them onto a 9-month, evidence-based lifestyle change programme, which is available as a face-to-face group service or as a digital service.[44]NHS England. NHS diabetes prevention programme (NHS DPP) [internet publication].
https://www.england.nhs.uk/diabetes/diabetes-prevention
Specific eligibility criteria for the programme are adults (aged 18-80 years) with NDH, or people with a history of previous gestational diabetes mellitus and normoglycaemia (HbA1c <42 mmol/mol; fasting plasma glucose <5.5 mmol/l).[44]NHS England. NHS diabetes prevention programme (NHS DPP) [internet publication].
https://www.england.nhs.uk/diabetes/diabetes-prevention
People on the programme receive personalised support to manage their weight, eat more healthily, and be more physically active, with the digital service utilising tools such as wearable technologies, apps where users can access health coaches, online peer-support groups, and the ability to set and monitor goals electronically.[44]NHS England. NHS diabetes prevention programme (NHS DPP) [internet publication].
https://www.england.nhs.uk/diabetes/diabetes-prevention
This programme has reduced the risk of developing type 2 diabetes by more than a third for people completing the course.[44]NHS England. NHS diabetes prevention programme (NHS DPP) [internet publication].
https://www.england.nhs.uk/diabetes/diabetes-prevention
Research shows that a combination of low-risk lifestyle behaviours, such as maintaining a healthy body weight, healthy diet, regular exercise, smoking abstinence or cessation, and light alcohol consumption, is associated with a lower risk of incident type 2 diabetes.[45]Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD). Evidence-based European recommendations for the dietary management of diabetes. Diabetologia. 2023 Jun;66(6):965-85.
https://link.springer.com/article/10.1007/s00125-023-05894-8
http://www.ncbi.nlm.nih.gov/pubmed/37069434?tool=bestpractice.com
[46]Khan TA, Field D, Chen V, et al. Combination of multiple low-risk lifestyle behaviors and incident type 2 diabetes: a systematic review and dose-response meta-analysis of prospective cohort studies. Diabetes Care. 2023 Mar 1;46(3):643-56.
https://diabetesjournals.org/care/article/46/3/643/148470/Combination-of-Multiple-Low-Risk-Lifestyle
http://www.ncbi.nlm.nih.gov/pubmed/36812419?tool=bestpractice.com
[47]Nabila S, Kim JE, Choi J, et al. Associations between modifiable risk factors and changes in glycemic status among individuals with prediabetes. Diabetes Care. 2023 Mar 1;46(3):535-43.
https://diabetesjournals.org/care/article-abstract/46/3/535/148255/Associations-Between-Modifiable-Risk-Factors-and?redirectedFrom=fulltext
http://www.ncbi.nlm.nih.gov/pubmed/36625739?tool=bestpractice.com
[48]Schlesinger S, Neuenschwander M, Ballon A, et al. Adherence to healthy lifestyles and incidence of diabetes and mortality among individuals with diabetes: a systematic review and meta-analysis of prospective studies. J Epidemiol Community Health. 2020 May;74(5):481-487.
http://www.ncbi.nlm.nih.gov/pubmed/32075860?tool=bestpractice.com
Further, with aggressive prevention of obesity in all age groups, type 2 diabetes is potentially preventable.[49]Evert AB, Dennison M, Gardner CD, et al. Nutrition therapy for adults with diabetes or prediabetes: a consensus report. Diabetes Care. 2019 May;42(5):731-54.
https://care.diabetesjournals.org/content/42/5/731.long
http://www.ncbi.nlm.nih.gov/pubmed/31000505?tool=bestpractice.com
[50]LeBlanc EL, Patnode CD, Webber EM, et al; Agency for Healthcare Research and Quality (US). Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: an updated systematic review for the U.S. Preventive Services Task Force. September 2018 [internet publication].
https://www.ncbi.nlm.nih.gov/books/NBK532379
http://www.ncbi.nlm.nih.gov/pubmed/30354042?tool=bestpractice.com
Several clinical trials have shown that weight loss is associated with delayed or decreased onset of type 2 diabetes in high-risk adults, and the European Association for the Study of Diabetes recommends that people with overweight or obesity should aim for at least a 5% weight loss by adopting an intensive lifestyle intervention.[31]Hemmingsen B, Gimenez-Perez G, Mauricio D, et al. Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst Rev. 2017 Dec 4;(12):CD003054.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003054.pub4/full
http://www.ncbi.nlm.nih.gov/pubmed/29205264?tool=bestpractice.com
[45]Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD). Evidence-based European recommendations for the dietary management of diabetes. Diabetologia. 2023 Jun;66(6):965-85.
https://link.springer.com/article/10.1007/s00125-023-05894-8
http://www.ncbi.nlm.nih.gov/pubmed/37069434?tool=bestpractice.com
[51]Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb 7;346(6):393-403.
https://www.nejm.org/doi/10.1056/NEJMoa012512
http://www.ncbi.nlm.nih.gov/pubmed/11832527?tool=bestpractice.com
[52]Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997 Apr;20(4):537-44.
http://www.ncbi.nlm.nih.gov/pubmed/9096977?tool=bestpractice.com
[53]Tuomilehto J, Lindström J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001 May 3;344(18):1343-50.
https://www.nejm.org/doi/full/10.1056/NEJM200105033441801
http://www.ncbi.nlm.nih.gov/pubmed/11333990?tool=bestpractice.com
[54]Knowler WC, Fowler SE, Hamman RF, et al; Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009 Nov 14;374(9702):1677-86.
http://www.ncbi.nlm.nih.gov/pubmed/19878986?tool=bestpractice.com
[55]Balk EM, Earley A, Raman G, et al. Combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task Force. Ann Intern Med. 2015 Sep 15;163(6):437-51.
https://annals.org/aim/fullarticle/2395729/combined-diet-physical-activity-promotion-programs-prevent-type-2-diabetes
http://www.ncbi.nlm.nih.gov/pubmed/26167912?tool=bestpractice.com
Progression to diabetes from NDH can be reduced by 50% over 3-4 years through modest weight loss (7% of body weight) using diet and regular physical activity.[51]Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002 Feb 7;346(6):393-403.
https://www.nejm.org/doi/10.1056/NEJMoa012512
http://www.ncbi.nlm.nih.gov/pubmed/11832527?tool=bestpractice.com
[
]
What are the effects of diet, physical activity, or both in people at increased risk of developing type 2 diabetes mellitus?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1974/fullShow me the answer In addition, several pharmacological agents, including metformin, alpha-glucosidase inhibitors, orlistat, glucagon-like peptide-1 (GLP-1) receptor agonists, and thiazolidinediones, have been shown to reduce progression from NDH to type 2 diabetes.[56]Gerstein HC, Yusuf S, Bosch J, et al; DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006 Sep 23;368(9541):1096-105.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(06)69420-8/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/16997664?tool=bestpractice.com
[57]Apolzan JW, Venditti EM, Edelstein SL, et al. Long-term weight loss with metformin or lifestyle intervention in the Diabetes Prevention Program Outcomes Study. Ann Intern Med. 2019 May 21;170(10):682-90.
http://www.ncbi.nlm.nih.gov/pubmed/31009939?tool=bestpractice.com
[58]Moelands SV, Lucassen PL, Akkermans RP, et al. Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst Rev. 2018 Dec 28;(12):CD005061.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD005061.pub3/full
http://www.ncbi.nlm.nih.gov/pubmed/30592787?tool=bestpractice.com
[59]Hemmingsen B, Sonne DP, Metzendorf MI, et al. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus. Cochrane Database Syst Rev. 2017 May 10;5(5):CD012204.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012204.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/28489279?tool=bestpractice.com
[60]Coleman RL, Scott CAB, Lang Z, et al. Meta-analysis of the impact of alpha-glucosidase inhibitors on incident diabetes and cardiovascular outcomes. Cardiovasc Diabetol. 2019 Oct 17;18(1):135.
https://cardiab.biomedcentral.com/articles/10.1186/s12933-019-0933-y
http://www.ncbi.nlm.nih.gov/pubmed/31623625?tool=bestpractice.com
[
]
In people with increased risk of developing type 2 diabetes mellitus, what are the preventative effects of alpha‐glucosidase inhibitors compared with exercise/diet or placebo or metformin?/cca.html?targetUrl=https://www.cochranelibrary.com/cca/doi/10.1002/cca.2511/fullShow me the answer
[
]
Can glucagon‐like peptide (GLP)‐1 analogs prevent or delay the development of type 2 diabetes?/cca.html?targetUrl=https://www.cochranelibrary.com/cca/doi/10.1002/cca.2574/fullShow me the answer
[
]
For people at risk for developing type 2 diabetes mellitus, how does metformin compare with diet and exercise?/cca.html?targetUrl=https://www.cochranelibrary.com/cca/doi/10.1002/cca.2991/fullShow me the answer Lifestyle change and/or metformin are preferred for most patients.[61]Roberts S, Barry E, Craig D, et al. Preventing type 2 diabetes: systematic review of studies of cost-effectiveness of lifestyle programmes and metformin, with and without screening, for pre-diabetes. BMJ Open. 2017 Nov 15;7(11):e017184.
https://bmjopen.bmj.com/content/7/11/e017184.long
http://www.ncbi.nlm.nih.gov/pubmed/29146638?tool=bestpractice.com
[62]Haw JS, Galaviz KI, Straus AN, et al. Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials. JAMA Intern Med. 2017 Dec 1;177(12):1808-17.
http://www.ncbi.nlm.nih.gov/pubmed/29114778?tool=bestpractice.com
[63]Herman WH, Pan Q, Edelstein SL, et al; Diabetes Prevention Program Research Group. Impact of lifestyle and metformin interventions on the risk of progression to diabetes and regression to normal glucose regulation in overweight or obese people with impaired glucose regulation. Diabetes Care. 2017 Dec;40(12):1668-77.
https://care.diabetesjournals.org/content/40/12/1668.long
http://www.ncbi.nlm.nih.gov/pubmed/29021207?tool=bestpractice.com
[64]Galaviz KI, Weber MB, Straus A, et al. Global diabetes prevention interventions: a systematic review and network meta-analysis of the real-world impact on incidence, weight, and glucose. Diabetes Care. 2018 Jul;41(7):1526-34.
https://care.diabetesjournals.org/content/41/7/1526.long
http://www.ncbi.nlm.nih.gov/pubmed/29934481?tool=bestpractice.com
More aggressive multi-agent pharmacological approaches remain controversial.[65]Armato JP, DeFronzo RA, Abdul-Ghani M, et al. Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES). Lancet Diabetes Endocrinol. 2018 Oct;6(10):781-9.
http://www.ncbi.nlm.nih.gov/pubmed/30224284?tool=bestpractice.com
Screening for NDH and cardiovascular risk reduction appropriate to the needs of the individual are also very important.[66]Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation. 2019 Sep 10;140(11):e596-e646.
https://www.ahajournals.org/doi/10.1161/CIR.0000000000000678
http://www.ncbi.nlm.nih.gov/pubmed/30879355?tool=bestpractice.com
[67]Rosenzweig JL, Bakris GL, Berglund LF, et al. Primary prevention of ASCVD and T2DM in patients at metabolic risk: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2019 Sep;104(9):3939-85.
https://academic.oup.com/jcem/article/104/9/3939/5540926
http://www.ncbi.nlm.nih.gov/pubmed/31365087?tool=bestpractice.com